Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study finds strong evidence of transplacental passage of IgG antibodies following COVID vaccination

In the current study, researchers investigate the transplacental transmission of antibodies in vaccinated pregnant women.

29 Sep 2021

A review of COVID-19 vaccine effectiveness

A new study systematically reviews vaccine efficacy and vaccine effectiveness (VE) of COVID-19 vaccines.

29 Sep 2021

SARS-CoV-2 viroporin activity impacts viral infectivity and pathogenicity

A team of researchers studied the two main viroporins of SARS-CoV-2, namely Orf3a and Envelope (E) protein, from a structural viewpoint.

29 Sep 2021

Large-scale SARS-CoV-2 spike protein mutants analysis identifies subclonal variants indicative of within-host viral diversity

Researchers have investigated a vast SARS-CoV-2 assembly and NGS data set to detect non-synonymous S protein mutations.

29 Sep 2021

Study finds correlation between neutralizing antibody titer and reported vaccine efficacy

An observational study compares immune responses against three vaccines.

29 Sep 2021

Vaccine-induced SARS-CoV2 immune responses decline at similar rates as those after infection, study finds

A new preprint describes the causal role of waning antibody titers in decreased antibody persistence at one year.

29 Sep 2021

Universal screening for SARS-CoV-2 among hospitalized patients may be ineffective

Universal screening of all hospital admissions for infection with SARS-CoV-2 is highly inefficient as a screening method in regions with a low prevalence of COVID-19 in the absence of high-risk factors.

29 Sep 2021

Peripheral nerve injuries and severe COVID-19

An interesting new study discusses the occurrence of peripheral nerve injuries in a subset of patients who survived severe COVID-19.

29 Sep 2021

Research finds increases in 'pandemic brain' after COVID-19 lockdowns

Chances are, the COVID-19 pandemic has affected your health — even if you have never been infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to new research from Harvard Medical School, the stress of isolation from lockdown and stay-at-home measures is making people sick.

29 Sep 2021

How effective are COVID-19 vaccines against SARS-CoV-2 variants of concern?

The authors from this paper performed a systematic review and meta-analysis evaluating vaccine effectiveness from RCTs and observational studies.

29 Sep 2021

Greater viral load of SARS-CoV-2 variants of concern increases transmission potential

By quantifying the probability of infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in accordance with its viral load after a high-risk contact, researchers from France, Spain, and the United Kingdom show a substantial correlation of transmission probability and viral load increase in variants of concern.

28 Sep 2021

Human coronavirus replicates in bats without using the spike protein

Researchers in Singapore have conducted a study showing active replication of a human coronavirus in bats that occurred without the viral spike protein binding to host cell receptors.

28 Sep 2021

Researchers model impact of changes in contact rate patterns on COVID-19 incidence in US

Researchers in the United States have studied changes in contact rate patterns in the United States over the course of the coronavirus disease 2019 (COVID-19) pandemic and modeled the impact that these changes have had on the incidence of cases across different age groups.

28 Sep 2021

Study shows Delta variant is main variant causing vaccine breakthrough COVID-19 infections, irrespective of manufacturer

In a recent study, researchers from Texas assessed the incidence of new SARS-CoV-2 variants of concern in the communities in Dallas-Fort Worth (DFW).

28 Sep 2021

Southeast Asia - A hotspot of many viruses with potential to cause pandemics

A new study reveals that scientists have found three viruses in bats in Laos that exhibit similar characteristic features as SARS-CoV-2.

28 Sep 2021

Quantification of antibody titers against SARS-CoV-2 variants elicited by BNT162b2 vaccine

A new study discusses the development of dedicated reagents against the SARS-CoV-2 spike protein through the use of an automated CLEIA system.

28 Sep 2021

A retrospective surveillance study of Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccination in Israel

One recent study provided nationwide estimates of the burden of SARS-CoV-2 that could be averted by Israel's vaccination campaign.

28 Sep 2021

The role of heating, ventilation, and air-conditioning in virus transmission, including SARS-CoV-2

A new study provides an overview of reviews to identify previous systematic reviews on HVAC systems and airborne transmission of infectious agents.

28 Sep 2021

The effectiveness of mRNA BNT162b2 vaccine in reducing severe COVID-19: Evidence from Germany

A new study discusses the epidemiology of the outbreak in German nursing homes and the preventive measures undertaken.

28 Sep 2021

NIAID awards approximately $36.3 million to fuel vaccine research for coronaviruses

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded approximately $36.3 million to three academic institutions to conduct research to develop vaccines to protect against multiple types of coronaviruses and viral variants.

28 Sep 2021

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study finds strong evidence of transplacental passage of IgG antibodies following COVID vaccination

A review of COVID-19 vaccine effectiveness

SARS-CoV-2 viroporin activity impacts viral infectivity and pathogenicity

Large-scale SARS-CoV-2 spike protein mutants analysis identifies subclonal variants indicative of within-host viral diversity

Study finds correlation between neutralizing antibody titer and reported vaccine efficacy

Vaccine-induced SARS-CoV2 immune responses decline at similar rates as those after infection, study finds

Universal screening for SARS-CoV-2 among hospitalized patients may be ineffective

Peripheral nerve injuries and severe COVID-19

Research finds increases in 'pandemic brain' after COVID-19 lockdowns

How effective are COVID-19 vaccines against SARS-CoV-2 variants of concern?

Greater viral load of SARS-CoV-2 variants of concern increases transmission potential

Human coronavirus replicates in bats without using the spike protein

Researchers model impact of changes in contact rate patterns on COVID-19 incidence in US

Study shows Delta variant is main variant causing vaccine breakthrough COVID-19 infections, irrespective of manufacturer

Southeast Asia - A hotspot of many viruses with potential to cause pandemics

Quantification of antibody titers against SARS-CoV-2 variants elicited by BNT162b2 vaccine

A retrospective surveillance study of Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccination in Israel

The role of heating, ventilation, and air-conditioning in virus transmission, including SARS-CoV-2

The effectiveness of mRNA BNT162b2 vaccine in reducing severe COVID-19: Evidence from Germany

NIAID awards approximately $36.3 million to fuel vaccine research for coronaviruses

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in